399 related articles for article (PubMed ID: 7923295)
21. Inhibitors of nitric oxide synthesis and ischemia/reperfusion attenuate coronary vasodilator response to pinacidil in isolated rat heart.
Maczewski M; Beresewicz A
J Physiol Pharmacol; 1997 Dec; 48(4):737-49. PubMed ID: 9444621
[TBL] [Abstract][Full Text] [Related]
22. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
Satoh H
J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
[TBL] [Abstract][Full Text] [Related]
23. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts.
Wolleben CD; Sanguinetti MC; Siegl PK
J Mol Cell Cardiol; 1989 Aug; 21(8):783-8. PubMed ID: 2506353
[TBL] [Abstract][Full Text] [Related]
24. Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes.
Escande D; Thuringer D; Le Guern S; Courteix J; Laville M; Cavero I
Pflugers Arch; 1989 Sep; 414(6):669-75. PubMed ID: 2510125
[TBL] [Abstract][Full Text] [Related]
25. Effects of ATP-dependent K+ channel modulators on an ischemia-reperfusion rabbit isolated heart model with programmed electrical stimulation.
Bellemin-Baurreau J; Poizot A; Hicks PE; Rochette L; Armstrong JM
Eur J Pharmacol; 1994 Apr; 256(2):115-24. PubMed ID: 8050462
[TBL] [Abstract][Full Text] [Related]
26. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
Yanagisawa T; Teshigawara T; Taira N
Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
[TBL] [Abstract][Full Text] [Related]
28. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
McPherson GA; Angus JA
Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
[TBL] [Abstract][Full Text] [Related]
29. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
[TBL] [Abstract][Full Text] [Related]
30. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
[TBL] [Abstract][Full Text] [Related]
31. Comparative relaxant effects of cromakalim and pinacidil on the tonic contraction of canine coronary artery induced by phorbol 12,13-dibutylate.
Kuromaru O; Sakai K
Clin Exp Pharmacol Physiol; 1996; 23(6-7):493-7. PubMed ID: 8800572
[TBL] [Abstract][Full Text] [Related]
32. [Effect of potassium channel openers on hypoxic pulmonary vasoconstriction].
Matsumoto H; Nakano H; Akiba Y; Osanai S; Tobise K; Onodera S
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1488-95. PubMed ID: 1434222
[TBL] [Abstract][Full Text] [Related]
33. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation.
McPherson CD; Pierce GN; Cole WC
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1809-18. PubMed ID: 8238595
[TBL] [Abstract][Full Text] [Related]
34. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN
Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
[TBL] [Abstract][Full Text] [Related]
35. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
McPherson GA; Stork AP
Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells.
Allard B; Lazdunski M
Eur J Pharmacol; 1993 Jun; 236(3):419-26. PubMed ID: 8359200
[TBL] [Abstract][Full Text] [Related]
37. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
Rees SA; Tsuchihashi K; Hearse DJ; Curtis MJ
J Cardiovasc Pharmacol; 1993 Sep; 22(3):343-9. PubMed ID: 7504122
[TBL] [Abstract][Full Text] [Related]
38. Effects of potassium channel blockers on the negative inotropic responses induced by cromakalim and pinacidil in guinea pig atrium.
Lau WM
Pharmacology; 1992; 45(1):9-16. PubMed ID: 1508969
[TBL] [Abstract][Full Text] [Related]
39. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.
McCullough JR; Normandin DE; Conder ML; Sleph PG; Dzwonczyk S; Grover GJ
Circ Res; 1991 Oct; 69(4):949-58. PubMed ID: 1934346
[TBL] [Abstract][Full Text] [Related]
40. Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide.
Gelband GH; McCullough JR
Am J Physiol; 1993 May; 264(5 Pt 1):C1119-27. PubMed ID: 8498475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
